1052. NV1020, a Genetically-Engineered Oncolytic Herpes Simplex Virus Type 1, for Human Colorectal Cancer Metastatic to the Liver

Genetically Engineered ◽

Human Colorectal Cancer ◽

Oncolytic herpes simplex virus type-1 expressing IL-12 efficiently replicates and kills human colorectal cancer cells

Microbial Pathogenesis ◽

10.1016/j.micpath.2021.105164 ◽

2021 ◽

pp. 105164

Author(s):

Nasrin Haghighi-Najafabadi ◽

Farzin Roohvand ◽

Mohammad Sadegh Shams Nosrati ◽

Ladan Teimoori-Toolabi ◽

Kayhan Azadmanesh

Keyword(s):

Colorectal Cancer ◽

Herpes Simplex Virus ◽

Herpes Simplex ◽

Human Colorectal Cancer ◽

Colorectal Cancer Cells ◽

Simplex Virus ◽

Human Colorectal Cancer Cells

Oncolytic viral therapy for human colorectal cancer and liver metastases using a multi‐mutated herpes simplex virus type‐1 (G207)

The FASEB Journal ◽

10.1096/fasebj.13.11.1325 ◽

1999 ◽

Vol 13 (11) ◽

pp. 1325-1334 ◽

Cited By ~ 114

Author(s):

David A. Kooby ◽

John F. Carew ◽

Marc W. Halterman ◽

Jonathan E. Mack ◽

Joseph R. Bertino ◽

...

Keyword(s):

Colorectal Cancer ◽

Herpes Simplex Virus ◽

Herpes Simplex ◽

Liver Metastases ◽

Virus Type ◽

Human Colorectal Cancer ◽

Viral Therapy ◽

664. Therapeutic Effect of Oncolytic Herpes Simplex Virus Type 1 (G47Δ) in Combination with Chemotherapy on Colorectal Cancer

Molecular Therapy ◽

10.1016/s1525-0016(16)33472-4 ◽

2016 ◽

Vol 24 ◽

pp. S263

Author(s):

Shinya Abe ◽

Yasushi Ino ◽

Hiroshi Fukuhara ◽

Miwako Iwai ◽

Toshiaki Watanabe ◽

...

Keyword(s):

Colorectal Cancer ◽

Herpes Simplex Virus ◽

Herpes Simplex ◽

Therapeutic Effect ◽

Virus Type ◽

778 ENHANCED EFFICACY OF ONCOLYTIC HERPES SIMPLEX VIRUS TYPE 1 (HSV-1) ARMED WITH IL-12 IN BLADDER CANCER MODELS

The Journal of Urology ◽

10.1016/j.juro.2010.02.1427 ◽

2010 ◽

Vol 183 (4S) ◽

Author(s):

Hiroshi Fukuhara ◽

Jiangang Hou ◽

Yuzuri Tsurumaki ◽

Yukio Homma ◽

Yasushi Ino ◽

...

Keyword(s):

Bladder Cancer ◽

Herpes Simplex Virus ◽

Herpes Simplex ◽

Virus Type ◽

Cancer Models ◽

Simplex Virus ◽

Hsv 1

Correction: Arming an Oncolytic Herpes Simplex Virus Type 1 with a Single-chain Fragment Variable Antibody against PD-1 for Experimental Glioblastoma Therapy

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-19-4091 ◽

2020 ◽

Vol 26 (3) ◽

pp. 758-758 ◽

Cited By ~ 1

Author(s):

Carmela Passaro ◽

Quazim Alayo ◽

Isabel DeLaura ◽

John McNulty ◽

Korneel Grauwet ◽

...

Keyword(s):

Herpes Simplex Virus ◽

Herpes Simplex ◽

Virus Type ◽

Single Chain ◽

Chain Fragment ◽

Single Chain Fragment Variable ◽

Experimental Therapy for Malignant Brain Tumors Using Genetically Engineered Herpes Simplex Virus Type 1

Brain Tumor ◽

10.1007/978-4-431-66887-9_42 ◽

1996 ◽

pp. 409-414

Author(s):

Toshihiro Mineta ◽

Samuel D. Rabkin ◽

Robert L. Martuza

Keyword(s):

Herpes Simplex Virus ◽

Herpes Simplex ◽

Brain Tumors ◽

Virus Type ◽

Genetically Engineered ◽

Experimental Therapy ◽

Malignant Brain Tumors ◽

Oncolytic Herpes Simplex Virus Type-1 Therapy in a Highly Infiltrative Animal Model of Human Glioblastoma

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-07-2000 ◽

2008 ◽

Vol 14 (5) ◽

pp. 1571-1580 ◽

Cited By ~ 11

Author(s):

Peter C. Huszthy ◽

Dorota Goplen ◽

Frits Thorsen ◽

Heike Immervoll ◽

Jian Wang ◽

...

Keyword(s):

Animal Model ◽

Herpes Simplex Virus ◽

Herpes Simplex ◽

Virus Type ◽

Human Glioblastoma ◽

Molecular engineering and validation of an oncolytic herpes simplex virus type 1 transcriptionally targeted to midkine-positive tumors

The Journal of Gene Medicine ◽

10.1002/jgm.1479 ◽

2010 ◽

Vol 12 (7) ◽

pp. 613-623 ◽

Cited By ~ 14

Author(s):

Arturo R. Maldonado ◽

Chuck Klanke ◽

Anil G. Jegga ◽

Bruce J. Aronow ◽

Yonatan Y. Mahller ◽

...

Keyword(s):

Herpes Simplex Virus ◽

Herpes Simplex ◽

Virus Type ◽

Molecular Engineering ◽

Imaging immediate-early and strict-late promoter activity during oncolytic herpes simplex virus type 1 infection and replication in tumors

Gene Therapy ◽

10.1038/sj.gt.3302831 ◽

2006 ◽

Vol 13 (24) ◽

pp. 1731-1736 ◽

Cited By ~ 19

Author(s):

S Yamamoto ◽

L A Deckter ◽

K Kasai ◽

E A Chiocca ◽

Y Saeki

Keyword(s):

Herpes Simplex Virus ◽

Herpes Simplex ◽

Virus Type ◽

Promoter Activity ◽

Immediate Early ◽

Late Promoter ◽

Oncolytic Herpes Simplex Virus Type 1 and Host Immune Responses

Current Cancer Drug Targets ◽

10.2174/156800907780058907 ◽

2007 ◽

Vol 7 (2) ◽

pp. 149-155 ◽

Cited By ~ 16

Author(s):

Hiroshi Fukuhara ◽

Tomoki Todo

Keyword(s):

Herpes Simplex Virus ◽

Herpes Simplex ◽

Immune Responses ◽

Virus Type ◽

Host Immune Responses ◽